Cargando…

Bioinformatics for precision oncology

Molecular profiling of tumor biopsies plays an increasingly important role not only in cancer research, but also in the clinical management of cancer patients. Multi-omics approaches hold the promise of improving diagnostics, prognostics and personalized treatment. To deliver on this promise of prec...

Descripción completa

Detalles Bibliográficos
Autores principales: Singer, Jochen, Irmisch, Anja, Ruscheweyh, Hans-Joachim, Singer, Franziska, Toussaint, Nora C, Levesque, Mitchell P, Stekhoven, Daniel J, Beerenwinkel, Niko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585151/
https://www.ncbi.nlm.nih.gov/pubmed/29272324
http://dx.doi.org/10.1093/bib/bbx143
_version_ 1783428651845419008
author Singer, Jochen
Irmisch, Anja
Ruscheweyh, Hans-Joachim
Singer, Franziska
Toussaint, Nora C
Levesque, Mitchell P
Stekhoven, Daniel J
Beerenwinkel, Niko
author_facet Singer, Jochen
Irmisch, Anja
Ruscheweyh, Hans-Joachim
Singer, Franziska
Toussaint, Nora C
Levesque, Mitchell P
Stekhoven, Daniel J
Beerenwinkel, Niko
author_sort Singer, Jochen
collection PubMed
description Molecular profiling of tumor biopsies plays an increasingly important role not only in cancer research, but also in the clinical management of cancer patients. Multi-omics approaches hold the promise of improving diagnostics, prognostics and personalized treatment. To deliver on this promise of precision oncology, appropriate bioinformatics methods for managing, integrating and analyzing large and complex data are necessary. Here, we discuss the specific requirements of bioinformatics methods and software that arise in the setting of clinical oncology, owing to a stricter regulatory environment and the need for rapid, highly reproducible and robust procedures. We describe the workflow of a molecular tumor board and the specific bioinformatics support that it requires, from the primary analysis of raw molecular profiling data to the automatic generation of a clinical report and its delivery to decision-making clinical oncologists. Such workflows have to various degrees been implemented in many clinical trials, as well as in molecular tumor boards at specialized cancer centers and university hospitals worldwide. We review these and more recent efforts to include other high-dimensional multi-omics patient profiles into the tumor board, as well as the state of clinical decision support software to translate molecular findings into treatment recommendations.
format Online
Article
Text
id pubmed-6585151
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-65851512019-06-25 Bioinformatics for precision oncology Singer, Jochen Irmisch, Anja Ruscheweyh, Hans-Joachim Singer, Franziska Toussaint, Nora C Levesque, Mitchell P Stekhoven, Daniel J Beerenwinkel, Niko Brief Bioinform Paper Molecular profiling of tumor biopsies plays an increasingly important role not only in cancer research, but also in the clinical management of cancer patients. Multi-omics approaches hold the promise of improving diagnostics, prognostics and personalized treatment. To deliver on this promise of precision oncology, appropriate bioinformatics methods for managing, integrating and analyzing large and complex data are necessary. Here, we discuss the specific requirements of bioinformatics methods and software that arise in the setting of clinical oncology, owing to a stricter regulatory environment and the need for rapid, highly reproducible and robust procedures. We describe the workflow of a molecular tumor board and the specific bioinformatics support that it requires, from the primary analysis of raw molecular profiling data to the automatic generation of a clinical report and its delivery to decision-making clinical oncologists. Such workflows have to various degrees been implemented in many clinical trials, as well as in molecular tumor boards at specialized cancer centers and university hospitals worldwide. We review these and more recent efforts to include other high-dimensional multi-omics patient profiles into the tumor board, as well as the state of clinical decision support software to translate molecular findings into treatment recommendations. Oxford University Press 2017-12-18 /pmc/articles/PMC6585151/ /pubmed/29272324 http://dx.doi.org/10.1093/bib/bbx143 Text en © The Author(s) 2017. Published by Oxford University Press. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Paper
Singer, Jochen
Irmisch, Anja
Ruscheweyh, Hans-Joachim
Singer, Franziska
Toussaint, Nora C
Levesque, Mitchell P
Stekhoven, Daniel J
Beerenwinkel, Niko
Bioinformatics for precision oncology
title Bioinformatics for precision oncology
title_full Bioinformatics for precision oncology
title_fullStr Bioinformatics for precision oncology
title_full_unstemmed Bioinformatics for precision oncology
title_short Bioinformatics for precision oncology
title_sort bioinformatics for precision oncology
topic Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585151/
https://www.ncbi.nlm.nih.gov/pubmed/29272324
http://dx.doi.org/10.1093/bib/bbx143
work_keys_str_mv AT singerjochen bioinformaticsforprecisiononcology
AT irmischanja bioinformaticsforprecisiononcology
AT ruscheweyhhansjoachim bioinformaticsforprecisiononcology
AT singerfranziska bioinformaticsforprecisiononcology
AT toussaintnorac bioinformaticsforprecisiononcology
AT levesquemitchellp bioinformaticsforprecisiononcology
AT stekhovendanielj bioinformaticsforprecisiononcology
AT beerenwinkelniko bioinformaticsforprecisiononcology